Atousa Hashemi

Atousa Hashemi

Auto-generated profile, based on publicly available information

Atousa Hashemi

Department of Molecular Medicine, University of Padua, Padua, Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2026 in Nature Communications
Verified
Journal Article
Open access
MMMaría Mateo-Tórtola
María Mateo-Tórtola
IHInga V. Hochheiser
Inga V. Hochheiser
GLGaopeng Li
Gaopeng Li
LFLukas Funk
Lukas Funk
AHAtousa Hashemi
Atousa Hashemi
ATANA TAPIA-ABELLAN
ANA TAPIA-ABELLAN
The NLRP3 inflammasome contributes to a wide range of conditions from infections to Alzheimer’s disease. NLRP3 forms an inactive decameric cage, that upon interaction with the trans-Golgi network (TGN) and microtubule organization center (MTOC), leads to inflammasome activation, yet whether non-decamer NLRP3 species form functional inflammasomes remains unclear. Here, we design a NLRP3 exon 3 deletion variant that forms low molecular weight NLRP3 assemblies. Spatially and dynamically highly resolved microscopy in THP-1 and human macrophages shows that nigericin, a K + -dependent NLRP3 stimulus, can trigger two distinct activation pathways: (i) the rapidly engaged decameric cage-dependent pathway; and (ii) a decameric cage-independent, TGN/MTOC-distal, and slow-reacting pathway employed by low molecular weight NLRP3 species, that dominates in human neutrophils. Collectively, our results delineate two parallel yet biologically distinct NLRP3 activation pathways, thereby providing a framework to understand NLRP3-driven inflammation across a wide range of pathological context and cell types.

1 January 2022 in International Clinical Neuroscience Journal
Verified
Journal Article
Open access
PDF file
PDPoorya Davoodi
Poorya Davoodi
AHAtousa Hashemi
Atousa Hashemi
NANegin Ahmadfakhredin
Negin Ahmadfakhredin
MJMelika Jourablou
Melika Jourablou
MAMeisam Akhlaghdoust
Meisam Akhlaghdoust
HMHasan Mosazadeh
Hasan Mosazadeh
The outbreak of coronavirus disease 2019 (COVID-19) has changed the typical lifestyle of people worldwide for nearly two years. Maybe before the onset of this pandemic, no one believed that a virus could change all aspects of life. COVID-19 has had a catastrophic effect worldwide, and it has led to more than 5 million deaths.1Since the beginning of the COVID-19 pandemic, different factors such as emotional and exaggerated images and news, rumors, and misinformation about the origins and causes of the disease, have affected the lifestyle of the people, and many people have lost their family or friends., all leading to increased anxiety.2 The results of studies in the previous pandemics have shown that one of the most critical domains of harm is the mental health of people and the significant point is that the mental health of infected individuals was less affected than non-infected individuals. During the COVID-19 pandemic, different studies have evaluated the mental health of people. Fear and anxiety are common feelings that are experienced by patients with or suspected of COVID-19. A study published in 2020 showed that fear of illness results in increased anxiety and stress levels in patients, healthy individuals or health workers.

1 January 2021 in Clinical and Experimental Vaccine Research
Verified
Journal Article
Open access
PDF file
PDPoorya Davoodi
Poorya Davoodi
AHAtousa Hashemi
Atousa Hashemi
Davoodi P, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):301-303. https://doi.org/10.7774/cevr.2021.10.3.301